Published November, 2010
By Leonard B. Saltz
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 0.00
Availability: Available

Management options for patients with colorectal cancer have undergone d- matic changes over the past decade. Whereas at the start of 1996 only one drug, 5-Fluorouracil, was available for the treatment of this disease, a mere 10 yr later, six drugs are licensed for use in colorectal cancer, and others are in the late phases of clinical development.

---

Published November, 2010
By Ching-Hon Pui
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 0.00
Availability: Available

---

Published November, 2010
By Michael H. Torosian
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 0.00
Availability: Available

---

Published August, 2010
By Christopher G. Willett, Brian Czito, Christopher Willett and Brian G. Czito
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 1.00
Availability: Available

Rectal Cancer: International Perspectives on Multimodality Management is a timely analysis of the diagnosis, staging, pathology, and therapy of cancer of the rectum.

---

Published May, 2010
By Michael J. Fisch, Jane E. Loitman and Christian T. Sinclair
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 0.00
Availability: Available

A clinical case-based handbook has a role in general clinicians' practice of caring for patients with serious or life-limiting illness. Thus, we hope that the cases, key points, and practical tips will help health care providers who are not experts already in palliative care in the care of patients with serious illness and challenging problems.

---

Published May, 2010
By G. David Roodman
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 0.00
Availability: Available

This book presents the forefront in the science and clinical management of myeloma bone disease. Coverage begins with sections on clinical presentation, imaging, and biochemical markers and goes on to discuss radiation, surgical, and medical therapies.

---

Published March, 2010
By David J. Stewart
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 0.00
Availability: Available

Defining the Lung Cancer Problem 1 Lung cancer is the leading cause of cancer death in the world. Lung cancer in people who have never smoked is currently the 5th 3 leading cause of cancer death in the United States.

---

Published December, 2009
By Maurie Markman and Razelle Kurzrock
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 1.00
Availability: Available

Emerging technologies in target identification, drug discovery, molecular markers, and imaging are rapidly changing the face of cancer. This book provides a foundation of knowledge in targeted cancer therapeutics.

---

Published October, 2009
By Brian I Carr
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 1.00
Availability: Contact supplier

Hepatocellular cancer is the fifth most common cancer. This book thoroughly updates and expands upon the critically acclaimed first edition with all the latest developments in the diagnosis and treatment of primary liver cancer.

---

Published July, 2009
By Antonio Giordano and Nicola Normanno
Publisher: Springer (Humana Press Inc.)
Series: Current Clinical Oncology
Rating: 0.00
Availability: Available

Breast cancer is the most common tumor in women. It is the second leading cause of cancer deaths worldwide. In this book, international authorities offer a comprehensive approach to the biology, diagnosis, prevention, and treatment of human breast carcinoma.

---